Abstract:Urogenital schistosomiasis caused by Schistosoma haematobium affects approximately 110 million people globally, with the majority of cases in low- and middle-income countries. Schistosome infections have been shown to impact the host immune system, gene expression, and microbiome composition. Studies have demonstrated variations in pathology between schistosome subspecies. In the case of S . haematobium , infection has been associated with HIV acquisition and bladder cancer. However, the underlying pathophysiology has been understudied compared to other schistosome species. This systematic review comprehensively investigates and assimilates the effects of S . haematobium infection on systemic and local host mucosal immunity, cellular gene expression and microbiome. We conducted a systematic review assessing the reported effects of S . haematobium infections and anthelmintic treatment on the immune system, gene expression and microbiome in humans and animal models. This review followed PRISMA guidelines and was registered prospectively in PROSPERO (CRD42022372607). Randomized clinical trials, cohort, cross-sectional, case-control, experimental ex vivo , and animal studies were included. Two reviewers performed screening independently. We screened 3,177 studies and included 94. S . haematobium was reported to lead to: (i) a mixed immune response with a predominant type 2 immune phenotype, increased T and B regulatory cells, and select pro-inflammatory cytokines; (ii) distinct molecular alterations that would compromise epithelial integrity, such as increased metalloproteinase expression, and promote immunological changes and cellular transformation, specifically upregulation of genes p53 and Bcl-2 ; and (iii) microbiome dysbiosis in the urinary, intestinal, and genital tracts. S . haematobium induces distinct alterations in the host's immune system, molecular profile, and microbiome. This leads to a diverse range of inflammatory and anti-inflammatory responses and impaired integrity of the local mucosal epithelial barrier, elevating the risks of secondary infections. Further, S . haematobium promotes cellular transformation with oncogenic potential and disrupts the microbiome, further influencing the immune system and genetic makeup. Understanding the pathophysiology of these interactions can improve outcomes for the sequelae of this devastating parasitic infection. The parasitic trematode S . haematobium affects 110 million people worldwide. Many studies have described the effects of schistosome infections on humans and animals, but data focusing solely on S . haematobium infections, which cause urogenital schistosomiasis are scarce. Our goal was to evaluate, in a systematic manner, how S . haematobium infection affects the immune system, gene expression and microbiome of the host. These effects are important because they could lead to increased risk of infections, such as HIV, and bladder cancer. We screened 3,179 studies for potential relevance and included 94 of them in this review. Our analysis showed that S . haematobium infection profoundly alters the immune system with a mixed pro-inflammatory and anti-inflammatory response, though with a predominant type 2 immune phenotype and increased regulatory cells. We further found consistent evidence that it impairs local mucosal epithelial barrier integrity, promotes cellular transformation with pro-oncogenic changes in the host, and is associated with microbial alterations in urine, stool, and genital tracts. We discuss how these findings might be interpreted, and the additional research needed, to improve our understanding of S . haematobium pathophysiology and ameliorate the potential sequelae of S . haematobium infection, such as increased viral infections and cancer.

Whole-genome Sequence of Schistosoma Haematobium.

Chromosome-level Genome of Schistosoma Haematobium Underpins Genome-Wide Explorations of Molecular Variation

Schistosoma mansoni Egg, Adult Male and Female Comparative Gene Expression Analysis and Identification of Novel Genes by RNA-Seq

The Schistosoma japonicum genome reveals features of host–parasite interplay

Schistosoma Genomics: New Perspectives on Schistosome Biology and Host-Parasite Interaction

Schistosome Transcriptomes: New Insights into the Parasite and Schistosomiasis

Systems Biomedical Analysis of Schistosoma Japonicum

Evolutionary and Biomedical Implications of a Schistosoma Japonicum Complementary DNA Resource

Chromosome‐level Genome Assembly Defines Female‐biased Genes Associated with Sex Determination and Differentiation in the Human Blood Fluke Schistosoma Japonicum

An "In-Depth" Description of the Small Non-Coding RNA Population of Schistosoma Japonicum Schistosomulum.

New Perspectives on Host-Parasite Interplay by Comparative Transcriptomic and Proteomic Analyses of Schistosoma Japonicum

Schistosome Transcriptome Analysis at the Cutting Edge

Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review

Schistosoma Japonicum: Modern Tools for an Ancient Disease

Single-cell transcriptomics of the human parasite Schistosoma mansoni first intra-molluscan stage reveals tentative tegumental and stem-cell regulators

A single-cell RNA-seq atlas of Schistosoma mansoni identifies a key regulator of blood feeding

SchistoDB: a Schistosoma mansoni genome resource.

Exploring the genome-wide transcriptomic responses of Bulinus truncatus to Schistosoma haematobium infection: An important host-parasite system involved in the transmission of human urogenital schistosomiasis

Population genomic analyses of schistosome parasites highlight critical challenges facing endgame elimination efforts

An improved genome assembly of the fluke Schistosoma japonicum

Homology-based annotation of non-coding RNAs in the genomes of Schistosoma mansoni and Schistosoma japonicum